Network Pharmacology to Uncover the Biological Basis of Spleen Qi Deficiency Syndrome and Herbal Treatment

Figure 2

The biomolecular network underlying SQD syndrome was constructed based on clinical phenotypes and protein-protein interactions. (a) SQD syndrome phenotype-biomolecule comodule network. (b) SQD syndrome immune biomolecular network (biomolecules with significant enrichment in immune biological processes and pathways are marked, ). (c) Validation of the SQD syndrome biomolecular network. (d) The predicted biomolecules of SQD syndrome that are not reported in the literature are upstream or in the same pathway.

(a)

(b)

(c)

(d)